
The certificate, which includes manufacturing and packaging of tablets and capsules in the non-potent and potent blocks of the facility, was issued based on a remote inspection in the week of March 22, 2021, in the wake of travel restrictions amidst COVID-19, the company added.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3d7Fb2w
via
IFTTT
0 comments:
Post a Comment